Cargando…
MicroRNA-133a and Myocardial Infarction
Myocardial infarction (MI) is the leading cause of morbidity and mortality in the world. The infarcted heart displays typical cell death cascades characterized by a loss of cells and fibrotic scarring in the myocardium. Cardiac hypertrophy and fibrosis largely contribute to ventricular wall thickeni...
Autores principales: | Xiao, Yi, Zhao, Jiling, Tuazon, Julian P., Borlongan, Cesar V., Yu, Guolong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719504/ https://www.ncbi.nlm.nih.gov/pubmed/30983393 http://dx.doi.org/10.1177/0963689719843806 |
Ejemplares similares
-
MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction
por: Chen, Yueqiu, et al.
Publicado: (2017) -
microRNA-1/133a and microRNA-206/133b clusters: Dysregulation and functional roles in human cancers
por: Nohata, Nijiro, et al.
Publicado: (2012) -
The Roles of MicroRNA-133 in Gynecological Tumors
por: Zhou, Yang, et al.
Publicado: (2022) -
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis
por: Wang, Feng, et al.
Publicado: (2013) -
Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes
por: de Gonzalo-Calvo, D., et al.
Publicado: (2017)